The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Transplantation

NCT ID: NCT06533592

Last Updated: 2024-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

284 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-28

Study Completion Date

2028-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the trial is to compare the effect of two end-to-end duct-to-duct anastomosis surgical techniques using the continuous suture method versus interrupted method (control group) on reducing the risk of bile leakages in the 90-day follow-up period after liver transplantation and other postoperative complications resulting from them i.e.: the occurrence of a critical stenosis in the duct-to-duct anastomosis within 90 days. In addition, as part of the research experiment, long-term biliary complications will be assessed, i.e. occurring over a period of more than 90 days (a 2-year observation period of patients was assumed).

As part of the trial 284 patients qualified for the procedure of liver transplantation from a deceased donor will be included, in whom end-to-end anastomosis of the bile ducts will be performed. After entering the study, patients will be randomized to one of the groups. In the group of 142 patients, duct-to-duct anastomosis will be performed using an interrupted suture (control group), and the remaining patients will be performed using the continuous suture technique.

The analysis will also include surgical complications, complications related to early and late graft function, retransplantation and overall survival.

Additionally the analyses an analysis of the impact of the occurrence of a biliary complication on the quality of life of patients after liver transplantation will be performed on the basis of the EORTC QLQ-C30 forms.

The period of observation of the patient after the procedure is planned for 24 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Transplant; Complications Bile Duct; Stricture, Postoperative Bile Leak Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous suture technique

Biliary duct-to-duct anastomosis performed with continous suture technique

Group Type EXPERIMENTAL

Continous suture technique

Intervention Type PROCEDURE

Duct-to-duct anastomosis will be performed using continuous suture technique for study group

Interrupted suture

Biliary duct-to-duct anastomosis performed with interrupted suture technique - control group

Group Type ACTIVE_COMPARATOR

Interrupted suture technique

Intervention Type PROCEDURE

Duct-to-duct anastomosis will be performed using an interrupted suture for control group,

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continous suture technique

Duct-to-duct anastomosis will be performed using continuous suture technique for study group

Intervention Type PROCEDURE

Interrupted suture technique

Duct-to-duct anastomosis will be performed using an interrupted suture for control group,

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age over 18
* elective liver transplantation
* informed consent to participate in the study
* recipient bile duct diameter over 3mm
* donor bile duct diameter over 3mm

Exclusion Criteria

* age below 18
* pregnancy
* living donor liver transplantation
* split-liver or reduced-size liver transplantation
* liver transplantation other than from brain death donor
* liver transplantation with hepaticojejunostomy
* patients undergoing re-transplantation
* multi-organ transplantation
* recipient bile duct diameter below 3mm
* donor bile duct diameter below 3mm
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Warsaw

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of General, Transplantation and Liver Surgery UCC MUW

Warsaw, Masovian Voivodeship, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Krzysztof Dudek, MD, PhD

Role: CONTACT

+48 225992542

Jan Stypułkowski, MD

Role: CONTACT

+48 225992459

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Krzysztof Dudek, MD, PhD

Role: primary

+48 225992542

Jan Stypułkowski, MD

Role: backup

+48 225992459

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/ABM/01/00017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dyed vs. Undyed Polyglactin Sutures in Cutaneous Surgery
NCT07078669 ENROLLING_BY_INVITATION NA
Emergency Intestinal Anastmosis
NCT07321743 COMPLETED NA